The treatment of chronic nonhealing wounds using autologous platelet-derived growth factors.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 8339079.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The treatment of chronic, nonhealing wounds is discussed. The authors have successfully utilized locally acting growth factors as an adjunct to aggressive, comprehensive management in a clinical setting. At the Holmes Regional Wound Care Center, wounds with an average duration of 75 weeks at presentation were 100% epithelialized in an average of 10 weeks of therapy. The use of topical PROCUREN, or autologous platelet-derived wound healing factors (PDWHF) is introduced to the podiatric literature.
Medical subject headings
- Platelet-Derived Growth Factor
- Wound Healing
- Wounds and Injuries